Avenue Therapeutics Inc logo

Avenue Therapeutics Inc Share Price Today (NASDAQ: ATXI)

Avenue Therapeutics Inc share price is $0 & ₹0.00 as on 18 Mar 2025 IST

▲

-0.42

(-100%)

Market is closed - opens 7 PM, 20 Jun 2025

Bell Icon

The stock has been delisted from the stock exchange on 19 Mar 2025

View live Avenue Therapeutics Inc share price in Dollar and Rupees. Guide to invest in Avenue Therapeutics Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Avenue Therapeutics Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Avenue Therapeutics Inc (ATXI) Key Statistics

in dollars & INR

Previous Close
$0.42
Open
$0.38
Market Capitalization
$862.6K
Today's Volume
$173.8K
Revenue TTM
$0.0
Earnings Per Share (EPS)
$24.78
PE Ratio
0.02
Profit Margin
0.0%
Quarterly Earnings Growth YOY
-0.76%
Return On Equity TTM
-535.1%

How to invest in Avenue Therapeutics Inc Stock (ATXI) from India?

It is very easy for Indian residents to invest directly in Avenue Therapeutics Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Avenue Therapeutics Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Avenue Therapeutics Inc or ATXI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Avenue Therapeutics Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Avenue Therapeutics Inc shares which would translate to null fractional shares of Avenue Therapeutics Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Avenue Therapeutics Inc, in just a few clicks!

Global Institutional Holdings in Avenue Therapeutics Inc

  • Ikarian Capital, LLC

    6.82%

  • BOOTHBAY FUND MANAGEMENT, LLC

    2.00%

  • UBS Group AG

    0.39%

  • Tower Research Capital LLC

    0.15%

  • Wells Fargo & Co

    0.02%

Analyst Recommendation on Avenue Therapeutics Inc

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Avenue Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Avenue Therapeutics Inc

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
Organization
Avenue Therapeutics Inc
Employees
3
CEO
Dr. Alexandra MacLean M.D.
Industry
Health Technology

Management People of Avenue Therapeutics Inc

NameTitle
Dr. Alexandra MacLean M.D.
CEO & Director
Mr. David Jin
Interim CFO, COO & Corporate Secretary
Dr. Lindsay Allan Rosenwald
Executive Director
Dr. Scott A. Reines M.D., Ph.D.
Interim Chief Medical Officer

Important FAQs about investing in ATXI Stock from India :

Can Indians buy Avenue Therapeutics Inc shares?

Yes, Indians can invest in the Avenue Therapeutics Inc (ATXI) from India.

With INDmoney, you can buy Avenue Therapeutics Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Avenue Therapeutics Inc at zero transaction cost.

How can I buy Avenue Therapeutics Inc shares from India?

It is very easy to buy Avenue Therapeutics Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Avenue Therapeutics Inc (ATXI) be purchased?

Yes, you can buy fractional shares of Avenue Therapeutics Inc with INDmoney app.

What are the documents required to start investing in Avenue Therapeutics Inc stocks?

To start investing in Avenue Therapeutics Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Avenue Therapeutics Inc?

Today's market capitalisation of Avenue Therapeutics Inc ATXI is 862.6K

Who is the Chief Executive Officer (CEO) of Avenue Therapeutics Inc ?

Dr. Alexandra MacLean M.D. is the current Chief Executive Officer (CEO) of Avenue Therapeutics Inc.